Using social media as a research recruitment tool: Ethical issues and recommendations L Gelinas, R Pierce, S Winkler, IG Cohen, HF Lynch, BE Bierer The American Journal of Bioethics 17 (3), 3-14, 2017 | 749 | 2017 |
A framework for ethical payment to research participants L Gelinas, EA Largent, IG Cohen, S Kornetsky, BE Bierer, ... New England Journal of Medicine 378 (8), 766-771, 2018 | 184 | 2018 |
Paying research participants: Regulatory uncertainty, conceptual confusion, and a path forward EA Largent, HF Lynch Yale journal of health policy, law, and ethics 17 (1), 61, 2017 | 184 | 2017 |
Ethics of controlled human infection to address COVID-19 SK Shah, FG Miller, TC Darton, D Duenas, C Emerson, HF Lynch, ... Science 368 (6493), 832-834, 2020 | 134 | 2020 |
Paying Research Participants: The Outsized Influence of “Undue Influence” EA Largent, HF Lynch IRB: Ethics & Human Research 39 (4), 2017 | 130 | 2017 |
Designing development programs for non-traditional antibacterial agents JH Rex, HF Lynch, IG Cohen, JJ Darrow, K Outterson Nature Communications 10 (1), 3416, 2019 | 71 | 2019 |
Conflicts of Conscience in Health Care: An Institutional Compromise HF Lynch MIT Press, 2008 | 71 | 2008 |
When clinical trials compete: prioritising study recruitment L Gelinas, HF Lynch, BE Bierer, IG Cohen Journal of Medical Ethics, 2017 | 57 | 2017 |
Opening closed doors: Promoting IRB transparency HF Lynch Journal of Law, Medicine & Ethics 46 (1), 145-158, 2018 | 56 | 2018 |
Ethical considerations for Zika virus human challenge trials SK Shah, J Kimmelman, AD Lyerly, HF Lynch, F McCutchan, FG Miller, ... National Institute of Allergy and Infectious Diseases, 2017 | 56 | 2017 |
Association Between Financial Incentives and Participant Deception About Study Eligibility HF Lynch, S Joffe, H Thirumurthy, D Xie, EA Largent JAMA network open 2 (1), e187355-e187355, 2019 | 55 | 2019 |
Compliance with advance directives: wrongful living and tort law incentives HF Lynch, M Mathes, NN Sawicki Journal of Legal Medicine 29 (2), 133-178, 2008 | 54 | 2008 |
Bystander risk, social value, and ethics of human research SK Shah, J Kimmelman, AD Lyerly, HF Lynch, FG Miller, R Palacios, ... Science 360 (6385), 158-159, 2018 | 51 | 2018 |
Federal right-to-try legislation—threatening the FDA’s public health mission S Joffe, HF Lynch New England Journal of Medicine 378 (8), 695-697, 2018 | 50 | 2018 |
Evaluating NFL player health and performance: Legal and ethical issues JL Roberts, IG Cohen, C Deubert, HF Lynch University of Pennsylvania Law Review 165, 227-314, 2017 | 49 | 2017 |
The right to withdraw from controlled human infection studies: justifications and avoidance H Fernandez Lynch Bioethics 34 (8), 833-848, 2020 | 39 | 2020 |
Of parachutes and participant protection: Moving beyond quality to advance effective research ethics oversight HF Lynch, S Nicholls, MN Meyer, HA Taylor, ... Journal of Empirical Research on Human Research Ethics 14 (3), 190-196, 2019 | 37 | 2019 |
Informed consent and the role of the treating physician HF Lynch, S Joffe, EA Feldman New England Journal of Medicine 378 (25), 2433-2438, 2018 | 37 | 2018 |
Revised ‘Common Rule’Shapes Protections For Research Participants BE Bierer, M Barnes, HF Lynch Health Affairs 36 (5), 784-788, 2017 | 37 | 2017 |
Nudging Health: Health Law and Behavioral Economics IG Cohen, HF Lynch, CT Robertson JHU Press, 2016 | 36 | 2016 |